Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Nextech (Group)

The global oncology specialist private equity firm Nextech Invest Ltd., established in 1998 in Zurich, Switzerland, focuses on investing in cancer companies. Supported by a Scientific Board of eight oncologists chaired by Prof. Dr. David Livingston, Deputy Director of Dana-Farber/Harvard Cancer Center, Nextech Invest invests in emerging companies with pioneering innovations in cancer that have compounds entering clinical trials. The other members of the Scientific Board include: Prof. Dr. Karl-Heinz Altmann, Prof. Dr. Philip Greenberg, Prof. Dr. William Kaelin, Dr. Charles Sawyers, Prof. Dr. Paul Workman, Dr. Kai Wucherpfennig and distinguished scientific advisor Prof. Dr. Sir Bruce Ponder. Nextech Invest is a longstanding member of SECA, and works closely with the Union for International Cancer Control (UICC). *


Period Start 2011-04-28 renamed before
  Today Nextech Invest Ltd. (CH)
  Predecessor Nextech Venture L.P.
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Persons Person Scheidegger, Alfred (Nextech Invest 201104 CEO + Founding Partner)
  Person 2 Schröder, Thilo (Nextech Invest 201607 Partner)
Region Region Zürich ZH
  Country Switzerland
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2021-04-05


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Nextech (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top